Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
A list of letters sent to healthcare professionals in November 2008 to inform of new safety information and advice.
|
Date issued
|
Product
|
Safety information
|
|---|---|---|
|
03/11/2008 |
Raptiva (efalizumab) |
Association with progressive multifocal leukoencephalopathy |
|
07/11/2008 |
Mabthera (rituximab) |
Association with progressive multifocal leukoencephalopathy |
